An Evaluation of the Efficacy of HEXI-PREP by Clinell Wipes

Inclusion Criteria: * Male and female participants 18 - 70 years, who have provided written informed consent to participate in the study * Test sites with a bacterial baseline count of ≥ 5.0 log10/cm2 at the inguinal (groin) test administration sites. ≥4.0 log10/cm2 at the abdominal test site and \>3.0 log10/cm2 at the clavicular and/or median cubital regions at Day - 5 of screening * Participants, who in the opinion of the Investigator, are in suitable health for inclusion in the study. Exclusion Criteria: * Exposure of the test sites to strong detergents, solvents or other irritants during the 14- day pre-test conditioning period or during the test period. * Use of systemic or topical antibiotic medications, steroid medications or any other product known to affect the normal microbial flora of the skin, up to 1 month prior to the screening period, during the 14-day pre-test conditioning period or during the test period. * Any known allergies to latex (rubber), alcohols, tape adhesives or to common antibacterial agents found in soaps, lotions or ointments, particularly chlorhexidine gluconate or chlorine. * Active skin rashes or breaks in the skin at the test site. * Active skin diseases or inflammatory skin conditions including contact dermatitis within 10cm of the test site. * Showering or bathing after the Day -5 baseline sampling and unwilling to refrain from showering or bathing whilst at Surrey CRC (Day 0 to Day 1). * Participation in another clinical trial within 90 days preceding randomisation. * Pregnant or breastfeeding women. * Any other medical condition, which in the opinion of the Investigator, should preclude participation. * Unwillingness to fulfil the performance requirements of the study.